CAPTRUST Financial Advisors
PROK icon

CAPTRUST Financial Advisors’s ProKidney PROK Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,454
Closed -$34K – 3528
2022
Q2 		$34K Sell
3,454
-6,515
-65% -$64.4K ﹤0.01% 3038
2022
Q1 		$99K Hold
9,969
– – ﹤0.01% 2283
2021
Q4 		$99K Hold
9,969
– – ﹤0.01% 2176
2021
Q3 		$98K Buy
+9,969
New +$98.2K ﹤0.01% 2095

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CAPTRUST Financial Advisors's PROK Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of ProKidney (PROK) in Q3 2022, closing a stake of 3,454 shares — an estimated $34K sold.

CAPTRUST Financial Advisors first reported a position in PROK in Q3 2021 and held it in 4 quarters. The position peaked at $99K in Q1 2022. 18 funds tracked by Wall St. Rank hold PROK as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining ProKidney position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 3,454 ProKidney shares in Q3 2022, an estimated $34K.
  • CAPTRUST Financial Advisors first reported a position in ProKidney in Q3 2021 and held it in 4 quarters.
  • CAPTRUST Financial Advisors's ProKidney position peaked at $99K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held ProKidney as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.